ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Bicara Therapeutics
8.76
-0.1800
-2.01%
成交量:
85.30万
成交额:
760.85万
市值:
4.78亿
市盈率:
-2.87
高:
9.28
开:
8.95
低:
8.48
收:
8.94
数据加载中...
总览
公司
新闻
公告
核心药物试验数据亮眼 大摩维持Bicara Therapeutics(BCAX.US)“买入”评级
智通财经网
·
05-28
BUZZ--美国股票走势-Oklo、铀股、工作日
路透中文
·
05-23
美国研究综述-嘉年华、卡特彼勒、Netflix
路透中文
·
05-16
美国研究综述-嘉年华、卡特彼勒、Netflix
路透中文
·
05-16
异动解读 | 分析师下调目标价,Bicara Therapeutics盘中大跌7.29%
异动解读
·
05-16
Bicara Therapeutics(BCAX.US):2025年Q1财报实现营收0美元;每股收益为-0.68美元,前值为-18.94美元,预期值为-0.38美元。
金融界
·
05-13
Bicara Therapeutics Inc.2024财年实现净利润-68.00百万美元,同比减少30.79%
市场透视
·
03-28
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BCAX/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BCAX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCAX\",,,,,undefined,":{"symbol":"BCAX","market":"US","secType":"STK","nameCN":"Bicara Therapeutics","latestPrice":8.76,"timestamp":1750966582655,"preClose":8.94,"halted":0,"volume":852959,"delay":0,"floatShares":28482543,"shares":54536218,"eps":-3.051868,"marketStatus":"交易中","change":-0.18,"latestTime":"06-26 15:36:38 EDT","open":8.95,"high":9.28,"low":8.48,"amount":7608482.987736001,"amplitude":0.089485,"askPrice":8.78,"askSize":318,"bidPrice":8.76,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.051868,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1750968000000},"marketStatusCode":2,"adr":0,"listingDate":1726200000000,"exchange":"NASDAQ","adjPreClose":8.94,"preHourTrading":{"tag":"盘前","latestPrice":9.24,"preClose":8.94,"latestTime":"08:43 EDT","volume":58,"amount":522,"timestamp":1750941808453},"postHourTrading":{"tag":"盘后","latestPrice":8.94,"preClose":8.94,"latestTime":"19:44 EDT","volume":3667,"amount":32785.55,"timestamp":1750895074234},"volumeRatio":1.354622,"impliedVol":0.963,"impliedVolPercentile":0.8415},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCAX\",,,,,undefined,":{"symbol":"BCAX","floatShares":28482543,"roa":"-13.84%","roe":"-27.26%","lyrEps":-4.045991,"volumeRatio":1.354622,"shares":54536218,"dividePrice":0,"high":9.28,"amplitude":0.089485,"preClose":8.94,"low":8.48,"week52Low":7.8,"pbRate":"1.04","week52High":28.09,"institutionHeld":0,"latestPrice":8.76,"committee":-0.521531,"eps":-3.051868,"divideRate":0,"volume":852959,"delay":0,"ttmEps":-3.051868,"open":8.95,"prevYearClose":17.42,"prevWeekClose":9.32,"prevMonthClose":9.25,"prevQuarterClose":13.03,"fiveDayClose":9.43,"twentyDayClose":9.46,"sixtyDayClose":13.03},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCAX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2538446059","title":"核心药物试验数据亮眼 大摩维持Bicara Therapeutics(BCAX.US)“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2538446059","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538446059?lang=zh_cn&edition=fundamental","pubTime":"2025-05-28 14:10","pubTimestamp":1748412642,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,摩根士丹利分析师Judah Frommer在美国生物技术公司Bicara Therapeutics公布Ficerafusp alfa的1/1b期临床试验中期数据后,维持对该股的“买入”评级,目标价保持在36美元。Ficerafusp alfa作为该公司的核心资产,是一款具有首创性的双功能抗体药物。据了解,Bicara Therapeutics是一家专注于开发实体瘤创新疗法的临床阶段生物制药公司。Frommer认为,这一数据相较标准治疗方案是重大突破,预示着Ficerafusp alfa有望在这一治疗难度较大的领域取得里程碑式进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1298497.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LENZ","BCAX"],"gpt_icon":0},{"id":"2537645153","title":"BUZZ--美国股票走势-Oklo、铀股、工作日","url":"https://stock-news.laohu8.com/highlight/detail?id=2537645153","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537645153?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 23:58","pubTimestamp":1748015917,"startTime":"0","endTime":"0","summary":".N 美国东部时间11:30,道琼斯工业平均指数.DJI下跌0.65%,报41587.30点。标普500指数.SPX下跌0.77%,报5797.10点;纳斯达克综合指数.IXIC下跌1.02%,报18732.06点。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nL4S3RV12J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDAY","NEM","GRDN","LU1429558221.USD","SCHW","FSLR","BK4182","CPRT","BLMZ","LU0053666078.USD","LU0203201768.USD","BAH","HNRG","IE00B4YYXB79.USD","BK4023","LU0477156797.USD","OKLO","09896","LU1316542783.SGD","LU2023250843.SGD","BCAX","NTCL","KKR","AAP","INTU","IMNN","IE0004445015.USD","LU0266512127.USD","BAC","APO","GDHG","MACW.SI","BK4099","DECK","FLR","LU1935043536.SGD","LU2249611893.SGD","LU2237438978.USD","GYRE","PMAX","ROST","IVZ","TSYW.SI","ENPH","DOUG","CEG"],"gpt_icon":1},{"id":"2535751319","title":"美国研究综述-嘉年华、卡特彼勒、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2535751319","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535751319?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 22:38","pubTimestamp":1747406285,"startTime":"0","endTime":"0","summary":"美国研究综述-嘉年华、卡特彼勒、Netflix路透5月16日 - 华尔街证券分析师周五调整了对嘉年华、卡特彼勒和 Netflix 等多家美国上市公司的评级和目标价。* Netflix Inc NFLX.O:Canaccord Genuity将目标价从1,200美元上调至1,380美元 * Watsco Inc WSO.N:瑞穗将目标价从490美元上调至525美元以下是路透周五报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nL4S3RO139:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4612","BOOT","BCAX","ADI","CADE","CSX","SG9999004303.SGD","ARCB","LU1815336760.USD","AMAT","CAT","LU1169590202.USD","CAVA","DOV","CCAP","DE","ED","ENR","ENOV","BK4534","LU1046421795.USD","GTLS","DDS","CCL","EMR","AMGN","MMM","IE00BD6J9T35.USD","LU0471298777.SGD","CHRW","TGT","CUBE","DKS","LU1548497426.USD","BRZE","DOCS","ATO","WMS","CARR","CCL.UK","CMMB","EVRG","CNX","AME","ABEO"],"gpt_icon":1},{"id":"2535319755","title":"美国研究综述-嘉年华、卡特彼勒、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2535319755","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535319755?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 22:38","pubTimestamp":1747406285,"startTime":"0","endTime":"0","summary":"美国研究综述-嘉年华、卡特彼勒、Netflix路透5月16日 - 华尔街证券分析师周五调整了对嘉年华、卡特彼勒和 Netflix 等多家美国上市公司的评级和目标价。要闻 * 嘉年华公司CCL.N:汇丰银行将其评级从 \"减持 \"上调至 \"持有 * 卡特彼勒公司CAT.N:瑞银将其评级从 \"卖出 \"上调至 \"中性\";将交易价从272美元上调至357美元 * Foot Locker Inc FL.N:摩根士丹利将其评级从 \"减持 \"上调至 \"等权重\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nL4T3RO139:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DKS","LU1548497426.USD","LU1046421795.USD","ABEO","TGT","CNX","CHRW","CUBE","CARR","AMAT","CSX","CCL.UK","CADE","IE00BD6J9T35.USD","EVRG","AMGN","AME","ADI","CMMB","LU1815336760.USD","DDS","DOCS","WMS","CAT","BK4612","CCL","ED","LU1169590202.USD","ARCB","CAVA","GTLS","ATO","DE","BCAX","EMR","BK4534","MMM","ENR","ENOV","BOOT","BRZE","DOV","CCAP","SG9999004303.SGD","LU0471298777.SGD"],"gpt_icon":1},{"id":"1104039039","title":"异动解读 | 分析师下调目标价,Bicara Therapeutics盘中大跌7.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=1104039039","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104039039?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 21:33","pubTimestamp":1747402383,"startTime":"0","endTime":"0","summary":"周五盘中,生物科技公司Bicara Therapeutics股价出现大幅下跌,截至发稿时跌幅达7.29%,引发投资者关注。造成股价下跌的主要原因是投资银行H.C. Wainwright下调了对Bicara Therapeutics的目标价。据悉,H.C. Wainwright将该公司的目标股价从44美元下调至41美元,降幅达6.82%。对于生物科技公司而言,这可能与研发进展、临床试验结果或市场竞争等因素有关。投资者可能需要密切关注Bicara Therapeutics未来的公司公告和行业动态,以评估其长期投资价值。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"异动解读 | 分析师下调目标价,Bicara Therapeutics盘中大跌7.29%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BCAX"],"gpt_icon":0},{"id":"2535722848","title":"Bicara Therapeutics(BCAX.US):2025年Q1财报实现营收0美元;每股收益为-0.68美元,前值为-18.94美元,预期值为-0.38美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535722848","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535722848?lang=zh_cn&edition=fundamental","pubTime":"2025-05-13 19:41","pubTimestamp":1747136462,"startTime":"0","endTime":"0","summary":"Bicara Therapeutics(BCAX.US):2025年Q1财报实现营收0美元;每股收益为-0.68美元,前值为-18.94美元,预期值为-0.38美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/13194150355618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","BCAX"],"gpt_icon":0},{"id":"2522522405","title":"Bicara Therapeutics Inc.2024财年实现净利润-68.00百万美元,同比减少30.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2522522405","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522522405?lang=zh_cn&edition=fundamental","pubTime":"2025-03-28 19:00","pubTimestamp":1743159625,"startTime":"0","endTime":"0","summary":"3月28日,Bicara Therapeutics Inc.公布财报,公告显示公司2024财年净利润为-68.00百万美元,同比减少30.79%;其中营业收入为0.00美元,每股基本收益为-1.25美元。机构评级:截至2025年3月28日,当前有5家机构对Bicara Therapeutics Inc.目标价做出预测,其中目标均价为41.60美元,其中最低目标价为31.00美元,最高目标价为48.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328190028a445441a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328190028a445441a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCAX","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCAX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"BCAX","fiscalQuarterEnding":"2025/03","expectedEps":-0.4,"name":null,"time":"盘前","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2025-03-27","symbol":"BCAX","fiscalQuarterEnding":"2024/12","expectedEps":-0.31,"name":null,"time":"盘前","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.39},{"market":"US","date":"2024-11-12","symbol":"BCAX","fiscalQuarterEnding":"2024/09","expectedEps":-0.46,"name":null,"time":"盘前","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCAX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCAX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.5714,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1748059200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BCAX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BCAX","date":"2025-06-25","current":-5.617054,"percent":0.963918,"low":-22.704836,"twenty":-18.716735,"median":-12.113097,"eighty":-9.526446,"high":-5.42214,"avg":-13.565169,"sd":4.650973,"marketCap":518639433},"quantilePoints":[{"date":"2024-09-13","current":-12.837909,"twenty":-12.837909,"median":-12.837909,"eighty":-12.837909,"marketCap":832435719},{"date":"2024-09-20","current":-20.633135,"twenty":-21.391361,"median":-20.283845,"eighty":-14.007791,"marketCap":1337893755},{"date":"2024-09-27","current":-21.555755,"twenty":-21.594337,"median":-21.446718,"eighty":-19.006626,"marketCap":1397718272},{"date":"2024-10-04","current":-19.962139,"twenty":-21.575885,"median":-21.337681,"eighty":-19.559541,"marketCap":1294385015},{"date":"2024-10-11","current":-15.936161,"twenty":-21.540658,"median":-20.570229,"eighty":-18.732598,"marketCap":1033332575},{"date":"2024-10-18","current":-17.143955,"twenty":-21.466848,"median":-20.283845,"eighty":-16.808457,"marketCap":1111648307},{"date":"2024-10-25","current":-18.964032,"twenty":-21.403103,"median":-19.23243,"eighty":-16.959431,"marketCap":1229665764},{"date":"2024-10-31","current":-19.878264,"twenty":-21.362844,"median":-19.23243,"eighty":-17.02653,"marketCap":1288946422},{"date":"2024-11-08","current":-19.79439,"twenty":-21.337681,"median":-19.82794,"eighty":-17.143955,"marketCap":1283507830},{"date":"2024-11-15","current":-20.345116,"twenty":-21.127995,"median":-19.949558,"eighty":-18.418848,"marketCap":1210086831},{"date":"2024-11-22","current":-16.257533,"twenty":-21.102833,"median":-19.82794,"eighty":-17.143955,"marketCap":966965549},{"date":"2024-11-29","current":-19.02049,"twenty":-20.975343,"median":-19.458892,"eighty":-17.009755,"marketCap":1131300719},{"date":"2024-12-06","current":-17.876882,"twenty":-20.695202,"median":-19.01323,"eighty":-17.12047,"marketCap":1063281195},{"date":"2024-12-13","current":-16.509127,"twenty":-20.532485,"median":-19.005969,"eighty":-17.12047,"marketCap":981929844},{"date":"2024-12-20","current":-15.187116,"twenty":-20.493904,"median":-18.892739,"eighty":-16.769874,"marketCap":903299275},{"date":"2024-12-27","current":-17.49263,"twenty":-20.458153,"median":-18.854995,"eighty":-16.764842,"marketCap":1040426635},{"date":"2025-01-03","current":-15.484454,"twenty":-20.399979,"median":-18.727694,"eighty":-16.641786,"marketCap":920984351},{"date":"2025-01-10","current":-13.952019,"twenty":-20.332862,"median":-18.565256,"eighty":-16.325863,"marketCap":829838189},{"date":"2025-01-17","current":-10.868852,"twenty":-20.271506,"median":-18.306879,"eighty":-15.951961,"marketCap":646457553},{"date":"2025-01-24","current":-10.951191,"twenty":-20.22215,"median":-18.224539,"eighty":-15.55307,"marketCap":651354959},{"date":"2025-01-31","current":-11.811185,"twenty":-20.138275,"median":-17.666458,"eighty":-14.949245,"marketCap":702505641},{"date":"2025-02-07","current":-11.52757,"twenty":-20.11652,"median":-17.561246,"eighty":-13.156068,"marketCap":685636799},{"date":"2025-02-14","current":-12.003311,"twenty":-19.978914,"median":-17.49263,"eighty":-12.003311,"marketCap":713932921},{"date":"2025-02-21","current":-12.643731,"twenty":-19.965494,"median":-17.085242,"eighty":-11.997822,"marketCap":752023854},{"date":"2025-02-28","current":-11.307997,"twenty":-19.942009,"median":-16.815614,"eighty":-11.891694,"marketCap":672577050},{"date":"2025-03-07","current":-14.409462,"twenty":-19.890007,"median":-16.73236,"eighty":-11.891694,"marketCap":857045999},{"date":"2025-03-14","current":-12.213735,"twenty":-19.838005,"median":-16.60519,"eighty":-11.893524,"marketCap":726448513},{"date":"2025-03-21","current":-11.975864,"twenty":-19.8011,"median":-16.394587,"eighty":-11.882546,"marketCap":712300452},{"date":"2025-03-28","current":-10.745093,"twenty":-19.525992,"median":-16.092853,"eighty":-11.882546,"marketCap":730612568},{"date":"2025-04-04","current":-9.486153,"twenty":-19.364339,"median":-15.936742,"eighty":-11.721526,"marketCap":645010946},{"date":"2025-04-11","current":-8.139007,"twenty":-19.311424,"median":-15.55307,"eighty":-11.500123,"marketCap":553411758},{"date":"2025-04-17","current":-9.430022,"twenty":-19.133936,"median":-15.269456,"eighty":-11.355571,"marketCap":641194313},{"date":"2025-04-25","current":-12.533268,"twenty":-19.02049,"median":-15.045308,"eighty":-11.297018,"marketCap":852199585},{"date":"2025-05-02","current":-11.795546,"twenty":-19.011777,"median":-14.409462,"eighty":-11.329955,"marketCap":802038125},{"date":"2025-05-09","current":-10.531076,"twenty":-18.980807,"median":-14.002338,"eighty":-11.242349,"marketCap":716060542},{"date":"2025-05-16","current":-8.546663,"twenty":-18.933837,"median":-13.265854,"eighty":-11.091295,"marketCap":789139074},{"date":"2025-05-23","current":-9.249533,"twenty":-18.888545,"median":-12.837909,"eighty":-10.95668,"marketCap":854037173},{"date":"2025-05-30","current":-5.575709,"twenty":-18.86506,"median":-12.634583,"eighty":-10.80298,"marketCap":514821897},{"date":"2025-06-06","current":-6.514837,"twenty":-18.854995,"median":-12.506498,"eighty":-10.643069,"marketCap":601534484},{"date":"2025-06-13","current":-6.833787,"twenty":-18.81138,"median":-12.341819,"eighty":-10.421008,"marketCap":630984042},{"date":"2025-06-20","current":-5.569802,"twenty":-18.738652,"median":-12.190862,"eighty":-10.145292,"marketCap":514276535},{"date":"2025-06-25","current":-5.617054,"twenty":-18.716735,"median":-12.113097,"eighty":-9.526446,"marketCap":518639433}],"updateTime":1750943757748}}}